Sector ratings Monte Rosa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 23:00:00 24/09/2026 +03			5-day change	1st Jan Change
11.72 ^USD	-1.43%		-6.98%	-25.26%

09-08	Top Midday Stories: GE Aerospace to Acquire Consolidated Precision Products; Qualcomm Issues Share Warrant to Amazon	MT
09-08	Monte Rosa Therapeutics Initiates Phase 2 Clinical Study for Vav1-Directed Molecular Glue Degrader MRT-6160	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
MONTE ROSA THERAPEUTICS, INC.	1B	-	BB	-	-
LONZA GROUP AG	48.01B		AAA
IQVIA HOLDINGS INC.	45.27B		AAA
BEONE MEDICINES AG	40.93B		-
REVOLUTION MEDICINES, INC.	42.84B	-	B	-	-
CELLTRION, INC.	29.6B		A
MEDPACE HOLDINGS, INC.	17.32B		BBB
EUROFINS SCIENTIFIC SE	15.34B		AA
ASCENDIS PHARMA A/S	15.15B	-	-	-	-
TEMPUS AI, INC.	14.84B		A		-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	14.06B		AA
ICON PUBLIC LIMITED COMPANY	13.42B		AAA
GENSCRIPT BIOTECH CORPORATION	11.56B		AA		-
BIO-TECHNE CORPORATION	11.38B		AA
PHARMARON BEIJING CO., LTD.	10.95B		AA
KYMERA THERAPEUTICS, INC.	9.63B	-	BBB	-	-
QIAGEN N.V.	9.22B		AAA
PROTAGONIST THERAPEUTICS, INC.	8.89B		BB		-
ABIVAX	8.07B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	7.87B	-	B	-	-
Average	18.77B		A
Weighted average by Cap.			A